← Leaderboards
John A. Petros
Emory University
$3,622,034
Attributed
$3,622,034
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $585.7K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$3,622,034 · 3
VA$0 · 1
By mechanism
P01$1,939,806 · 1
R01$1,311,390 · 1
R21$370,838 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Sean R Stowell$18,165,764
- James C. Zimring$24,599,687
- Jeanne E Hendrickson$9,770,113
- John D Roback$16,074,929
- Nourine Ahmed Kamili$189,066
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsSpecimenLaboratoriesAffectMalignant - DescriptorSiteGene MutationNuclearBiologyMitochondriaReactive Oxygen SpeciesMalignant PhenotypeMutationMitochondrial Dna MutationMalignant Neoplasm Of ProstateResearch StudyCellsGeneticCancer CellPc3 Cell LineComplexGrowthPositioning AttributeRespiratory
Grant awards (16)
Novel Diagnostic Tests for Renal Cell Carcinoma$0
I01 · FY2019 · VA · contact PI
Novel Diagnostic Tests for Renal Cell Carcinoma$0
I01 · FY2018 · VA · contact PI
Novel Diagnostic Tests for Renal Cell Carcinoma$0
I01 · FY2017 · VA · contact PI
Novel Diagnostic Tests for Renal Cell Carcinoma$0
I01 · FY2016 · VA · contact PI
Mitochondrial DNA Mutations in Prostate Tumorigenesis and Stromal-Epithelial Inte$372,469
P01 · FY2013 · CA · contact PI
Mitochondrial DNA Mutations in Prostate Tumorigenesis and Stromal-Epithelial Inte$385,225
P01 · FY2012 · CA · contact PI
Mitochondrial Genetics in Prostate Cancer Health Disparity$168,563
R21 · FY2012 · CA · contact PI
Mitochondrial DNA Mutations in Prostate Tumorigenesis and Stromal-Epithelial Inte$383,422
P01 · FY2011 · CA · contact PI
Mitochondrial Genetics in Prostate Cancer Health Disparity$202,275
R21 · FY2011 · CA · contact PI
Mitochondrial DNA Mutations in Prostate Tumorigenesis and Stromal-Epithelial Inte$395,910
P01 · FY2010 · CA · contact PI
Mitochondrial DNA Mutations in Prostate Tumorigenesis and Stromal-Epithelial Inte$402,780
P01 · FY2009 · CA · contact PI
Mitochondrial DNA in Mutations in Prostate Cancer$241,430
R01 · FY2006 · CA · contact PI
Mitochondrial DNA in Mutations in Prostate Cancer$247,240
R01 · FY2005 · CA
Mitochondrial DNA in Mutations in Prostate Cancer$247,240
R01 · FY2004 · CA
Mitochondrial DNA in Mutations in Prostate Cancer$281,240
R01 · FY2003 · CA
Mitochondrial DNA in Mutations in Prostate Cancer$294,240
R01 · FY2002 · CA